StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.04 (-2.34%)

Close on Nov 19, 2026Market cap $1.37MP/E –Yield –

Genprex shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Genprex's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 1M, up 1063.9% from the year before. The highest annual figure on record is 1M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+1063.9%
FY2024Dec 31, 20240M+193.0%
FY2023Dec 31, 20230M+14.1%
FY2022Dec 31, 20220M+1.8%
FY2021Dec 31, 20210M+32.6%
FY2020Dec 31, 20200M+121.7%
FY2019Dec 31, 20190M+16.4%
FY2018Dec 31, 20180M+19.8%
FY2017Dec 31, 20170M+6.1%
FY2016Dec 31, 20160M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20260M+55.0%
Q1 FY2026Mar 31, 20267M+9829.6%
Q3 FY2025Sep 30, 20251M+1658.8%
Q2 FY2025Jun 30, 20250M-22.0%
Q1 FY2025Mar 31, 20250M+926.5%
Q3 FY2024Sep 30, 20240M+142.2%
Q2 FY2024Jun 30, 20240M+66.4%
Q1 FY2024Mar 31, 20240M+30.8%
Q4 FY2023Dec 31, 20230M+23.8%
Q3 FY2023Sep 30, 20230M+20.5%
Q2 FY2023Jun 30, 20230M+8.5%
Q1 FY2023Mar 31, 20230M+3.3%
Q4 FY2022Dec 31, 20220M+0.5%
Q3 FY2022Sep 30, 20220M+0.8%
Q2 FY2022Jun 30, 20220M+1.1%
Q1 FY2022Mar 31, 20220M+5.1%
Q4 FY2021Dec 31, 20210M+20.6%
Q3 FY2021Sep 30, 20210M+21.9%
Q2 FY2021Jun 30, 20210M+34.0%
Q1 FY2021Mar 31, 20210M+62.9%
Q4 FY2020Dec 31, 20200M+129.2%
Q3 FY2020Sep 30, 20200M+146.7%
Q2 FY2020Jun 30, 20200M+126.3%
Q1 FY2020Mar 31, 20200M+82.3%
Q4 FY2019Dec 31, 20190M+14.5%
Q3 FY2019Sep 30, 20190M+7.9%
Q2 FY2019Jun 30, 20190M+15.6%
Q1 FY2019Mar 31, 20190M+30.7%
Q4 FY2018Dec 31, 20180M+31.6%
Q3 FY2018Sep 30, 20180M+26.1%
Q2 FY2018Jun 30, 20180M+17.7%
Q1 FY2018Mar 31, 20180M+3.1%
Q4 FY2017Dec 31, 20170M-0.2%
Q3 FY2017Sep 30, 20170M+6.9%
Q2 FY2017Jun 30, 20170M–
Q1 FY2017Mar 31, 20170M–
Q4 FY2016Dec 31, 20160M–
Q3 FY2016Sep 30, 20160M–

More Genprex figures

See a number that looks wrong?